Share
News
-
22 January 2010 /Side effects and trials
European Medicines Agency recommends suspension of marketing authorisations for sibutramine due to increased risk of cardiovascular events
Sibutramine is a medicine used to promote weight loss, which has been marketed in Denmark since 2001 under the name Reductil®.
-
15 January 2010 /Side effects and trials
Side effects from Pandemrix® from 19 December 2009 to 8 January 2010
In the period from 19 December 2009 to 8 January 2010, the Danish Medicines Agency received 32 new side effect reports covering a total of 73 suspected side effects (adverse reactions).
-
08 January 2010 /Side effects and trials
Minutes of the Pharmacovigilance Working Party's meeting held on 21-23 September.
The Pharmacovigilance Working Party (PhVWP) under EMEA's Committee for Medicinal Products for Human Use (CHMP) held its September 2009 plenary meeting on 21-23 September 2009.
-
07 January 2010 /Side effects and trials
Side effects from Eltroxin® - status January 2010
The Danish Medicines Agency has recorded an increase in the number of reported side effects from Eltroxin®. The increase is observed after the manufacturer changed the excipients contained in Eltroxin®.
-
04 January 2010 /Side effects and trials
Side effects from Pandemrix® from 12 to 18 December 2009
In the period from 12 to 18 December, the Danish Medicines Agency received 48 new side effect reports covering a total of 121 suspected side effects (adverse reactions).
